skip to content
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012. Preview this item
ClosePreview this item
Checking...

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.

Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
Publisher: Washington : U.S. Government Printing Office, Washington, DC : For sale by the Superintendent of Documents, U.S. Government Printing Office 2013.
Edition/Format:   Print book : National government publication : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Rules
Additional Physical Format: Online version:
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
(OCoLC)855764785
Microfiche version:
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
(OCoLC)861617562
Material Type: Government publication, National government publication, Internet resource
Document Type: Book, Internet Resource
All Authors / Contributors: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
OCLC Number: 855764761
Notes: Shipping list no.: 2013-0316-P.
"Serial no. 112-114."
Description: iv, 194 pages : illustrations ; 24 cm

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/855764761> # Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
    a schema:Book, schema:CreativeWork ;
    library:oclcnum "855764761" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Place/united_states> ; # United States.
    schema:about <http://id.worldcat.org/fast/898661> ; # Drug approval
    schema:about <http://id.worldcat.org/fast/922527> ; # Fees, Administrative
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/drug_accessibility> ; # Drug accessibility
    schema:about <http://id.worldcat.org/fast/1749120> ; # Drug accessibility
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/fees_administrative_united_states> ; # Fees, Administrative--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/biologicals_government_policy_united_states> ; # Biologicals--Government policy--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/generic_drugs_government_policy> ; # Generic drugs--Government policy
    schema:about <http://id.loc.gov/authorities/classification/KF27> ;
    schema:about <http://viaf.org/viaf/151271988> ; # United States. Food and Drug Administration
    schema:about <http://id.loc.gov/authorities/subjects/sh2009123884> ; # Drug approval--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/generic_drugs_government_policy_united_states> ; # Generic drugs--Government policy--United States
    schema:about <http://id.worldcat.org/fast/1204155> ; # United States
    schema:about <http://id.worldcat.org/fast/939971> ; # Generic drugs--Government policy
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/drug_accessibility_united_states> ; # Drug accessibility--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Organization/united_states_food_and_drug_administration> ; # United States. Food and Drug Administration
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/drug_approval> ; # Drug approval
    schema:about <http://experiment.worldcat.org/entity/work/data/1411314116#Topic/fees_administrative> ; # Fees, Administrative
    schema:author <http://viaf.org/viaf/146910626> ; # United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
    schema:bookFormat bgn:PrintBook ;
    schema:datePublished "2013" ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/1411314116> ;
    schema:genre "Rules"@en ;
    schema:genre "National government publication"@en ;
    schema:genre "Government publication"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/855764785> ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/861617562> ;
    schema:name "Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012."@en ;
    schema:productID "855764761" ;
    schema:url <http://purl.fdlp.gov/GPO/gpo39088> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/855764761> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/1411314116#Organization/united_states_food_and_drug_administration> # United States. Food and Drug Administration
    a schema:Organization ;
    schema:name "United States. Food and Drug Administration" ;
    schema:name "United States. Food and Drug Administration." ;
    .

<http://experiment.worldcat.org/entity/work/data/1411314116#Place/united_states> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://experiment.worldcat.org/entity/work/data/1411314116#Topic/biologicals_government_policy_united_states> # Biologicals--Government policy--United States
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh90002675> ;
    schema:name "Biologicals--Government policy--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411314116#Topic/drug_accessibility> # Drug accessibility
    a schema:Intangible ;
    schema:name "Drug accessibility"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411314116#Topic/fees_administrative> # Fees, Administrative
    a schema:Intangible ;
    schema:name "Fees, Administrative"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411314116#Topic/generic_drugs_government_policy> # Generic drugs--Government policy
    a schema:Intangible ;
    schema:name "Generic drugs--Government policy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1411314116#Topic/generic_drugs_government_policy_united_states> # Generic drugs--Government policy--United States
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh89000501> ;
    schema:name "Generic drugs--Government policy--United States"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2009123884> # Drug approval--United States
    a schema:Intangible ;
    schema:name "Drug approval--United States"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States
    a schema:Place ;
    schema:name "United States" ;
    .

<http://id.worldcat.org/fast/1749120> # Drug accessibility
    a schema:Intangible ;
    schema:name "Drug accessibility"@en ;
    .

<http://id.worldcat.org/fast/898661> # Drug approval
    a schema:Intangible ;
    schema:name "Drug approval"@en ;
    .

<http://id.worldcat.org/fast/922527> # Fees, Administrative
    a schema:Intangible ;
    schema:name "Fees, Administrative"@en ;
    .

<http://id.worldcat.org/fast/939971> # Generic drugs--Government policy
    a schema:Intangible ;
    schema:name "Generic drugs--Government policy"@en ;
    .

<http://purl.fdlp.gov/GPO/gpo39088>
    rdfs:comment "Permanent link" ;
    .

<http://viaf.org/viaf/146910626> # United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health,
    a schema:Organization ;
    schema:name "United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health," ;
    .

<http://viaf.org/viaf/151271988> # United States. Food and Drug Administration
    a schema:Organization ;
    schema:name "United States. Food and Drug Administration" ;
    .

<http://www.worldcat.org/oclc/855764785>
    a schema:CreativeWork ;
    rdfs:label "Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages" ;
    schema:description "Online version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/855764761> ; # Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
    .

<http://www.worldcat.org/oclc/861617562>
    a schema:CreativeWork ;
    rdfs:label "Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages" ;
    schema:description "Microfiche version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/855764761> ; # Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
    .

<http://www.worldcat.org/title/-/oclc/855764761>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/855764761> ; # Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
    schema:dateModified "2018-05-27" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.